Henry Schein Inc (HSIC) Company Sales Revenue

Henry Schein, Inc. (HSIC) transitioning to "green" supplies requires expenditures, yet the shift in the company's sales as reported by the GURU.Markets platform confirms the resilience of its model. Cyberattack and inflation risks are mitigated by deep integration into clinic procurement, which creates a stable order flow. Meanwhile, 13.73 serves as the final level marker, locking in current revenue to assess long-term yield potential.

HSIC Henry Schein Dental: Company Sales in the range 07/04/2022 - 11/15/2026

Comprehensive metric breakdowns and analytics for Henry Schein Dental (HSIC)

- current price and projected stock value:

Share Price henryschein.com|HSIC - Price Target Chart

- market capitalization details:

Market Value Henry Schein Dental|HSIC - Real Price to Acquire Entire Company

- balance sheet net asset value indicators:

Net Asset Value per Share Henry Schein|HSIC - Company Net Assets|Market Value to Book Value henryschein.com|HSIC - Aggregate Company Assets

- debt obligations and liquidity statistics:

- business earnings and investment ratios data:

HSIC - Company Net Income|Net Profit Forecast Henry Schein, Inc.|HSIC - Price to Earnings Ratio|Future Price to Earnings Multiple Henry Schein|HSIC - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Henry Schein Corp|HSIC - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months Henry Schein|HSIC - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months henryschein.com|HSIC - Net earnings per share growth this year|Consensus forecast of earnings per share growth for next year Henry Schein, Inc.

- issuer revenue and sales details:

HSIC - Revenue and Sales Volume|Company Future Revenue henryschein.com|HSIC - Price-to-Revenue Ratio|Market Cap to Expected Sales Ratio Henry Schein Inc

Summary company analysis:Henry Schein, Inc. - HSIC

Manufactured product of Henry Schein Corp

Henry Schein, Inc. (HSIC) maintains inelastic demand due to its status as a global medical technology supplier, making the company's current sales volume a fundamental indicator of cash flow resilience. Daily revenue price action allows investors to filter out market noise and assess the business's real liquidity, where stable metrics confirm FCF predictability and protect capital from volatility during periods of external shocks.

Key competitors